Inhibition of the protease activity in tracheobronchial aspirates of horses with chronic obstructive pulmonary disease.

This research explores the role of proteolytic enzymes in horses with chronic obstructive pulmonary disease (COPD) and proposes potential treatments to mitigate the proteolytic damage in their lungs.

About the Research

• This study was designed to understand the role of proteolytic enzymes in the development of chronic obstructive pulmonary disease (COPD) in horses. Proteolytic enzymes are proteins that break down other proteins, and their excess or uncontrolled activity can contribute to tissue damage.
• The researchers also wanted to explore new treatment avenues for COPD in horses by interfering with these proteolytic enzymes.

Methods

• The researchers studied the antiproteolytic activity of selected protease inhibitors on tracheal aspirates (a sample obtained from the trachea) in vitro, meaning in a controlled lab environment outside a living organism.
• The inhibition profiles obtained were compared with those of purified proteases (enzymes that break down proteins) to understand the pattern and effectiveness of the inhibition process.
• The research involved respiratory tract secretions obtained from 9 horses diagnosed with COPD.
• To assess the activity of enzymes in the secretions, a Caseinolytic agar-diffusion assay was used. This is a method to measure proteolytic activity, which is the capacity to break down proteins.

Results and Conclusions

• The results showed that the proteases-inhibition profile varied from horse to horse and didn’t resemble that of any of the pure proteases, indicating a complex protease activity in every individual case.
• Amongst the different inhibitors studied, Acetylcysteine, Pentamidine, and Diminazene were most effective at inhibiting proteolytic activity in tracheal aspirates in a lab setting.
• These results led to the conclusion that a mixed type of proteolytic activity is present in the respiratory tract secretions of horses with COPD.
• The effective inhibitors, Acetylcysteine, Pentamidine, and Diminazene could possibly be used as a treatment to protect the lungs of horses with COPD from proteolytic damage.